Table 1.

Clinical Information on the Breast Cancer Specimens Analyzed

ID	Age, y	HER2 Status	ER Status	PR Status	Lymph Node Status	Tumor Type	Tumor Size, cm	Nottingham Grade
10	49	N	Negative	Negative	Negative	Ductal	1.5	III
28	50	N	Negative	Negative	Negative	Ductal	2.2	III
30	45	N	Negative	Negative	Negative	Ductal	2.4	III
34	60	A	Negative	Negative	Negative	Ductal	5.0	III
36	45	N	Negative	Negative	Negative	Ductal	1.5	III
11	30	N	Negative	Negative	Negative	Ductal	1.0	III
25	80	N	Negative	Negative	Positive	Ductal	3.2	III
32	71	N	Negative	Negative	Negative	Ductal	1.8	II
52	56	N	Negative	Negative	Negative	Ductal	1.7	III
54	58	A	Negative	Negative	Positive	Ductal	2.2	III
40	41	N	Positive	Positive	Positive	Ductal	2.5	III
42	55	N	Positive	Positive	Positive	Ductal	1.5	II
20	70	N	Positive	Positive	Negative	Ductal	1.0	III
27	60	N	Positive	Positive	Positive	Ductal	1.7	II
29	66	N	Positive	Positive	Negative	Ductal	2.8	II
37	54	N	Positive	Positive	Positive	Ductal	3.2	III
53	36	N	Positive	Positive	Positive	Ductal	1.9	I
59	52	N	Positive	Positive	Negative	Ductal	2.0	II
60	91	N	Positive	Positive	Negative	Lobular	1.0	II
61	66	N	Positive	Negative	Negative	Lobular	1.1	II
62	65	N	Positive	Positive	Negative	Ductal	1.0	II

ID indicates identification number; HER2, human epidermal growth factor receptor 2; ER, estrogen receptor; PR, progesterone receptor; N, nonamplified; A, amplified.